Literature DB >> 16390894

A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.

Paul B Fitzgerald1, Jessica Benitez, Anthony de Castella, Z Jeff Daskalakis, Timothy L Brown, Jayashri Kulkarni.   

Abstract

OBJECTIVE: High-frequency left-side repetitive transcranial magnetic stimulation (rTMS) and low-frequency stimulation to the right prefrontal cortex have both been shown to have antidepressant effects, but doubts remain about the magnitude of previously demonstrated treatment effects. The authors evaluated sequentially combined high-frequency left-side rTMS and low-frequency rTMS to the right prefrontal cortex for treatment-resistant depression.
METHOD: The authors conducted a 6-week double-blind, randomized, sham-controlled trial in 50 patients with treatment-resistant depression. Three trains of low-frequency rTMS to the right prefrontal cortex of 140 seconds' duration at 1 Hz were applied daily, followed immediately by 15 trains of 5 seconds' duration of high-frequency left-side rTMS at 10 Hz. Sham stimulation was applied with the coil angled at 45 degrees from the scalp, resting on the side of one wing of the coil. The primary outcome variable was the score on the Montgomery-Asberg Depression Rating Scale.
RESULTS: There was a significantly greater response to active than sham stimulation at 2 weeks and across the full duration of the study. A significant proportion of the study group receiving active treatment met response (11 of 25 [44%]) or remission (nine of 25 [36%]) criteria by study end compared to the sham stimulation group (two of 25 [8%] and none of 25 respectively).
CONCLUSIONS: Sequentially applying both high-frequency left-side rTMS and low-frequency rTMS to the right prefrontal cortex, has substantial treatment efficacy in patients with treatment-resistant major depression. The treatment response accumulates to a clinically meaningful level over 4 to 6 weeks of active treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390894     DOI: 10.1176/appi.ajp.163.1.88

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  54 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 2.  Brain stimulation in psychiatry and its effects on cognition.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

3.  Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression.

Authors:  Alexander McGirr; Sneha Karmani; Rashmi Arsappa; Marcelo T Berlim; Jagadisha Thirthalli; Kesavan Muralidharan; Lakshmi N Yatham
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

Review 4.  Neuroplasticity and swallowing.

Authors:  Ruth E Martin
Journal:  Dysphagia       Date:  2009-01-07       Impact factor: 3.438

5.  Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.

Authors:  Laura E Leggett; Lesley J J Soril; Stephanie Coward; Diane L Lorenzetti; Gail MacKean; Fiona M Clement
Journal:  Prim Care Companion CNS Disord       Date:  2015-11-05

Review 6.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 7.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

8.  Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

Authors:  Andre R Brunoni; Renerio Fraguas; Felipe Fregni
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

9.  Improved discrimination of visual stimuli following repetitive transcranial magnetic stimulation.

Authors:  Michael L Waterston; Christopher C Pack
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

10.  Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

Authors:  Matthew P Ward; Pedro P Irazoqui
Journal:  Front Neuroeng       Date:  2010-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.